Recent company announcements on PROSTVAC™
29 April 2010 Bavarian Nordic Receives FDA Fast Track Designation for PROSTVAC™
9 March 2010 Bavarian Nordic Successfully Completes End of Phase II Meeting for PROSTVAC™
26 January 2010 PROSTVAC™ paper published in Journal of Clinical Oncology
21 September 2009 New and interesting PROSTVAC™ data indicate broad therapeutic use in metastatic prostate cancer
01 July 2009 New Review on PROSTVAC™ published by key Investigators from NCI
30 May 2009 PROSTVAC™ data presented at the ASCO Meeting demonstrates the potential for significant increases in life expectancy in late-stage prostate cancer
16 April 2009 PROSTVAC™ data accepted for an oral presentation at the ASCO Annual Meeting
25 February 2009 Bavarian Nordic reports further data on PROSTVAC™
